If you liked this article you might like

Why Durata Therapeutics (DRTX) Stock Hit a One-Year High Today
5 Stocks Moving on Unusual Volume
Emerging 'Superbugs' -- and Why Investors Should Care
2014 FDA Drug Approval Decision Calendar